The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best hot stocks to buy for June. On June 8, RBC Capital reiterated an Outperform rating on Revolution Medicines Inc. (NASDAQ:RVMD) and a $182 price target.

The research firm remains bullish on the company’s outlook for candidate drug daraxonrasib (formerly referred to as daraxibart), which demonstrated an overall survival benefit in patients with metastatic pancreatic cancer. The candidate drug has demonstrated significant, clinically meaningful improvements in progression-free survival (PFS) and overall survival (OS) compared with the standard of care.

According to RBC Capital, the positive clinical trials strengthen Revolution Medicine’s position in the pancreatic ductal adenocarcinoma market. Consequently, it expects the company to become a leader in the space on daraxibart, achieving $5.6 billion in peak sales by combining with other treatment regimens.

Pancreatic cancer is the most RAS-addicted of all major cancers, with patients harboring tumors driven by mutations in RAS proteins. The positive clinical trial results validate the company’s ability to target common RAS-addicted cancers through RAS(ON).

Revolution Medicines Inc. (NASDAQ:RVMD) is a clinical-stage precision oncology company that discovers and develops targeted therapies for patients with RAS-addicted cancers. Their focus is on developing specialized drugs called RAS(ON) inhibitors that target and block the specific proteins driving tumor growth in hard-to-treat diseases such as pancreatic, lung, and colorectal cancers.

While we acknowledge the potential of RVMD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 8 Best Defensive Stocks to Buy Amid Geopolitical Tensions and 10 Best Forever Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey on Google News.